Source: American Journal of Ophthalmology Case Reports. Unidade: FMRP
Subjects: TOXOPLASMOSE, MEDICAMENTO, INFECÇÕES BACTERIANAS, UVEÍTE, PROCEDIMENTOS CIRÚRGICOS OFTALMOLÓGICOS
ABNT
JORGE, Rodrigo et al. Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis. American Journal of Ophthalmology Case Reports, v. 22, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ajoc.2021.101093. Acesso em: 02 nov. 2024.APA
Jorge, R., Coelho, I. N., Silva-Cunha, A., Cunha, G. M. F., Scott, I. U., Fialho, S. L., & Furtado, J. M. F. (2021). Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis. American Journal of Ophthalmology Case Reports, 22. doi:10.1016/j.ajoc.2021.101093NLM
Jorge R, Coelho IN, Silva-Cunha A, Cunha GMF, Scott IU, Fialho SL, Furtado JMF. Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis [Internet]. American Journal of Ophthalmology Case Reports. 2021 ; 22[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ajoc.2021.101093Vancouver
Jorge R, Coelho IN, Silva-Cunha A, Cunha GMF, Scott IU, Fialho SL, Furtado JMF. Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis [Internet]. American Journal of Ophthalmology Case Reports. 2021 ; 22[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ajoc.2021.101093